glp 1 and 2 agonist GLP-1 receptor agonists for individualized treatment of type diabetes mellitus GLP-1 and Anesthesia: Considerations and

The kidney in heart failure: an update

Even then, the magnitude of the effect we observed was so large that this will most likely stand the test of time and represent a meaningful improvement in ablation outcomes for the strategy of adjunctive and riskfactor modification when applied before the procedure, as done in LEAF

Publicprivate partnerships and outcome-based reimbursement models may further facilitate equitable access while ensuring sustainability in health budgets

While these drugs have gained increased attention in the past decade, GLP-1, as a hormone, was first identified in the eighties

The cardiovascular benefits of GLP-1 RAs are further supported by considerable preclinical and clinical research, which show that these agents exert favourable modulatory effects on atherosclerosis itself and its risk factors [10]

doi: 10.3390/antiox10081166